Trial Profile
The Effects of Inhaled Nitric Oxide on Patient Morbidity and Length of Hospital Stay Following Fontan Operation
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 22 May 2023
Price :
$35
*
At a glance
- Drugs Nitric oxide (Primary)
- Indications Pleural effusion
- Focus Therapeutic Use
- 26 Apr 2023 Time frame of primary endpoint has been changed from 2 weeks to until hospital discharge.
- 03 May 2012 Actual patient number added 21 according to ClinicalTrials.gov.
- 03 May 2012 Actual end date (December 2011) added as reported by ClinicalTrials.gov.